Table 1. Baseline Characteristics of the Study Subjects Who Were Prescribed SGLT2 Inhibitors (n = 50).

Age	48 ± 10
Sex (male/female)	18/32
Body height (cm)	161 ± 8
Body weight (kg)	84.9 ± 17.6
Body mass index (BMI) (kg/m2)	32.1 ± 5.9
Systolic blood pressure (mm Hg)	130 ± 15
Diastolic blood pressure (mm Hg)	80 ± 11
Plasma glucose (mg/dL)	180 ± 75
Hemoglobin A1c (%)	8.9 ± 2.0